21 May 2009
Frequency of pseudomonas aeruginosa infections in lung transplant recipients in silesian center for heart disease in Zabrze
E Wozniak-Grygiel, M Siola, S Zeglen, J Wojarski, M ZembalaAnn Transplant 2009; 14(1): 73-73 :: ID: 880467
Abstract
Background: Lower respiratory tract infection remains a leading cause of
morbidity and mortality after solid organ transplantation. The particularly
increased susceptibility to infection is especially in the early post-transplant
period, at the initial stage of immunosuppression, also due to direct contact
with hospital environment, by the mechanical lung inhalation, biopsies, injections, bronchoscopy, bladder and vessels catheterization and because of the impaired clearance mechanisms after denervation of the transplanted lung. Airway colonisation with Pseudomonas, especially Pseudomonas aeruginosa, is common in lung transplant (LTx) recipients. Therefore, we performed a retrospective analysis to answer what is the frequency of P. aeruginosa infections in our Centre.
Material/Methods: From January 2001 to December 2008 in Silesian Center for Heart Disease 33 LTx were performed (including 4 heart-lung transplantation, 6 double and 23 single lung transplantations). The respiratory samples were the main diagnostic material and the routine microbiological methods were performed.
Results: P. aeruginosa in 13 patients was isolated (39.4% of all 33 LTx). In 10
cases (30.3% of all 33 LTx) airway colonization together with lower respiratory tract infection were observed. In the recent four years the P. aeruginosa was diagnosed in about 50% of LTx patients at a given year (i.e. in the scale of given year in 2005: 33.3%; 2006: 57.1%; 2007: 42.9%; 2008: 40%).
Conclusions: Lung transplant recipients in our centre are still at high risk for
Pseudomonas airway colonisation and lower respiratory tract infection what has a significant impact on the post-operative outcome.
Keywords: Lung Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






